0001562180-21-007666.txt : 20211213 0001562180-21-007666.hdr.sgml : 20211213 20211213203739 ACCESSION NUMBER: 0001562180-21-007666 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211209 FILED AS OF DATE: 20211213 DATE AS OF CHANGE: 20211213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DECICCO CARL CENTRAL INDEX KEY: 0001828727 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39634 FILM NUMBER: 211489450 MAIL ADDRESS: STREET 1: 100 BINNEY STREET STREET 2: SUITE 610 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Foghorn Therapeutics Inc. CENTRAL INDEX KEY: 0001822462 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 TECHNOLOGY SQUARE STREET 2: SUITE 700 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-586-3100 MAIL ADDRESS: STREET 1: 500 TECHNOLOGY SQUARE STREET 2: SUITE 700 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2021-12-09 false 0001822462 Foghorn Therapeutics Inc. FHTX 0001828727 DECICCO CARL 500 TECHNOLOGY SQUARE STE 700 CAMBRIDGE MA 02139 false true false false Chief Scientific Officer Common Stock 2021-12-09 4 M false 104310.00 3.72 A 362707.00 D Stock Options (Right to buy) 3.72 2021-12-09 4 M false 76892.00 0.00 D 2029-02-20 Common Stock 76892.00 186571.00 D Stock Options (Right to buy) 3.72 2021-12-09 4 M false 27418.00 0.00 D 2029-02-20 Common Stock 27418.00 34273.00 D The option vested as to 25% of the underlying shares of common stock on December 10, 2019, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested. The option vested as to 25% of the underlying shares of common stock on January 30, 2020, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested. /s /Allan Reine, M.D., Attorney-in-Fact 2021-12-13